The Best Of BioTech IQ

Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!

A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel 09/24/2025

Biotech Chief People Officer Discusses How To Build Company Culture 09/17/2025

Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO's Perspective With Tariq Arshad, MD 09/10/2025

Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick 09/03/2025

Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon 08/27/2025

Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh 08/20/2025

Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper 08/13/2025

Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis 08/06/2025

Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development? 07/30/2025

Global Tensions And Supply Chains And Their Effect On Biotech. Guillermo Morales, PhD, CEO Of Innoventyx 07/23/2025

Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD 07/16/2025

How Is Translational Genomics Reducing Background Noise In Multi-Disease Detection? With Aiguo "Adam" Zhang 07/09/2025

Addressing One Of The World’s Biggest Drivers Of Disease: Inflammation With Jim Woody, M.D., Ph.D. - CEO 180 Life Sciences 07/02/2025

#35 Can Biomea Change the World with Irreversible Drugs and Covalent Bonds? Thomas Butler, CEO - Biomea Fusion 06/25/2025

#33 Reducing friction at Clinical Trial Start-Up - Sam Searcy, CEO of CliniStart 06/18/2025

#32 People, the most valuable asset a business has. Brenda Sousa - Chief HR Officer 06/11/2025

#31 Managing CRO relationships and unique business models - Stewart Hallet - COO SFJ Pharmaceuticals 06/04/2025

#30 Brazen Bio Part II - Live and In Person! 05/28/2025

#29 Why do we resist? Applying clinical psychology to clinical trials. Kathleen Starr, PhD - EVP Behavioral Insights, Syneos Health 05/21/2025

#28 Vaccine Durability, Diversified Pipeline, Winning Strategy - Seth Lederman, MD - CEO Tonix Pharmaceuticals 05/14/2025

#27 How do you effectively manage the CMC process? With Doug Looker, PhD 05/07/2025

#26 How do you know the right path of development? Mike Rea, CEO - IDEA Pharma 04/30/2025

#25 Potential Tumor Immunity? Grant Yonehiro, CBO - Bolt BioTherapeutics 04/23/2025

#24 A fellowship program for biotech founders? Meet: Brazen Bio 04/16/2025

#23 Targeting treatment related toxicities - Michael McCullar - CEO OnQuality Pharmaceuticals 04/09/2025

#22 Regulatory Affairs Strategy w/Dr. Jethro Ekuta - VP, Global RA 04/02/2025

#21 Research and Development Tax Credits 03/26/2025

#20 Can longevity really be extended? Eric Leire, MD - CEO GenFlow Biosciences 03/19/2025

#19 Bing Du, MD - Senior Director, Global Patient Safety - BeiGene, Ltd. 03/12/2025

#18 Ed Tucker, MD, MBA - Chief Medical Officer - Mirum Pharmaceuticals 03/05/2025